483 related articles for article (PubMed ID: 26987538)
1. Circulating Tumor Cells.
Paoletti C; Hayes DF
Adv Exp Med Biol; 2016; 882():235-58. PubMed ID: 26987538
[TBL] [Abstract][Full Text] [Related]
2. Prospective assessment of the prognostic value of circulating tumor cells and their clusters in patients with advanced-stage breast cancer.
Mu Z; Wang C; Ye Z; Austin L; Civan J; Hyslop T; Palazzo JP; Jaslow R; Li B; Myers RE; Jiang J; Xing J; Yang H; Cristofanilli M
Breast Cancer Res Treat; 2015 Dec; 154(3):563-71. PubMed ID: 26573830
[TBL] [Abstract][Full Text] [Related]
3. Circulating tumor cells in breast cancer: functional heterogeneity, pathogenetic and clinical aspects.
Cherdyntseva NV; Litviakov NV; Denisov EV; Gervas PA; Cherdyntsev ES
Exp Oncol; 2017 Mar; 39(1):2-11. PubMed ID: 28361862
[TBL] [Abstract][Full Text] [Related]
4. Enumeration and molecular characterization of circulating tumor cells as an innovative tool for companion diagnostics in breast cancer.
Harigopal M; Kowalski D; Vosoughi A
Expert Rev Mol Diagn; 2020 Aug; 20(8):815-828. PubMed ID: 32546017
[TBL] [Abstract][Full Text] [Related]
5. Establishment of a multimarker qPCR panel for the molecular characterization of circulating tumor cells in blood samples of metastatic breast cancer patients during the course of palliative treatment.
Bredemeier M; Edimiris P; Tewes M; Mach P; Aktas B; Schellbach D; Wagner J; Kimmig R; Kasimir-Bauer S
Oncotarget; 2016 Jul; 7(27):41677-41690. PubMed ID: 27223437
[TBL] [Abstract][Full Text] [Related]
6. Association of clinical outcomes in metastatic breast cancer patients with circulating tumour cell and circulating cell-free DNA.
Ye Z; Wang C; Wan S; Mu Z; Zhang Z; Abu-Khalaf MM; Fellin FM; Silver DP; Neupane M; Jaslow RJ; Bhattacharya S; Tsangaris TN; Chervoneva I; Berger A; Austin L; Palazzo JP; Myers RE; Pancholy N; Toorkey D; Yao K; Krall M; Li X; Chen X; Fu X; Xing J; Hou L; Wei Q; Li B; Cristofanilli M; Yang H
Eur J Cancer; 2019 Jan; 106():133-143. PubMed ID: 30528798
[TBL] [Abstract][Full Text] [Related]
7. Clinical challenges in the molecular characterization of circulating tumour cells in breast cancer.
Lianidou ES; Mavroudis D; Georgoulias V
Br J Cancer; 2013 Jun; 108(12):2426-32. PubMed ID: 23756869
[TBL] [Abstract][Full Text] [Related]
8. Identification of high independent prognostic value of nanotechnology based circulating tumor cell enumeration in first-line chemotherapy for metastatic breast cancer patients.
Liu XR; Shao B; Peng JX; Li HP; Yang YL; Kong WY; Song GH; Jiang HF; Liang X; Yan Y
Breast; 2017 Apr; 32():119-125. PubMed ID: 28157583
[TBL] [Abstract][Full Text] [Related]
9. Circulating tumor cells as a predictive biomarker in patients with hormone-sensitive prostate cancer.
Goodman OB; Symanowski JT; Loudyi A; Fink LM; Ward DC; Vogelzang NJ
Clin Genitourin Cancer; 2011 Sep; 9(1):31-8. PubMed ID: 21705286
[TBL] [Abstract][Full Text] [Related]
10. Circulating tumor cells in patients with breast cancer: monitoring chemotherapy success.
Ušiaková Z; Mikulová V; Pintérová D; Brychta M; Valchář J; Kubecová M; Tesařová P; Bobek V; Kološtová K
In Vivo; 2014; 28(4):605-14. PubMed ID: 24982230
[TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of circulating tumour cells enumerated after filtration enrichment in early and metastatic breast cancer patients.
Wong NS; Kahn HJ; Zhang L; Oldfield S; Yang LY; Marks A; Trudeau ME
Breast Cancer Res Treat; 2006 Sep; 99(1):63-9. PubMed ID: 16541316
[TBL] [Abstract][Full Text] [Related]
12. Prognostic Impact of Circulating Tumor Cell Detected Using a Novel Fluidic Cell Microarray Chip System in Patients with Breast Cancer.
Sawada T; Araki J; Yamashita T; Masubuchi M; Chiyoda T; Yunokawa M; Hoshi K; Tao S; Yamamura S; Yatsushiro S; Abe K; Kataoka M; Shimoyama T; Maeda Y; Kuroi K; Tamura K; Sawazumi T; Minami H; Suda Y; Koizumi F
EBioMedicine; 2016 Sep; 11():173-182. PubMed ID: 27495793
[TBL] [Abstract][Full Text] [Related]
13. Circulating tumor cells in breast cancer: detection systems, molecular characterization, and future challenges.
Lianidou ES; Markou A
Clin Chem; 2011 Sep; 57(9):1242-55. PubMed ID: 21784769
[TBL] [Abstract][Full Text] [Related]
14. Towards a personalized breast cancer treatment approach guided by circulating tumor cell (CTC) characteristics.
Onstenk W; Gratama JW; Foekens JA; Sleijfer S
Cancer Treat Rev; 2013 Nov; 39(7):691-700. PubMed ID: 23683721
[TBL] [Abstract][Full Text] [Related]
15. Biomarker utility of circulating tumor cells in metastatic cutaneous melanoma.
Khoja L; Lorigan P; Zhou C; Lancashire M; Booth J; Cummings J; Califano R; Clack G; Hughes A; Dive C
J Invest Dermatol; 2013 Jun; 133(6):1582-90. PubMed ID: 23223143
[TBL] [Abstract][Full Text] [Related]
16. Sustained prognostic impact of circulating tumor cell status and kinetics upon further progression of metastatic breast cancer.
Jauch SF; Riethdorf S; Sprick MR; Schütz F; Schönfisch B; Brucker SY; Deutsch TM; Nees J; Saini M; Becker LM; Burwinkel B; Sinn P; Marmé F; Pantel K; Jäger D; Sohn C; Trumpp A; Wallwiener M; Schneeweiss A
Breast Cancer Res Treat; 2019 Jan; 173(1):155-165. PubMed ID: 30276763
[TBL] [Abstract][Full Text] [Related]
17. Dissecting the Heterogeneity of Circulating Tumor Cells in Metastatic Breast Cancer: Going Far Beyond the Needle in the Haystack.
Bulfoni M; Turetta M; Del Ben F; Di Loreto C; Beltrami AP; Cesselli D
Int J Mol Sci; 2016 Oct; 17(10):. PubMed ID: 27783057
[TBL] [Abstract][Full Text] [Related]
18. Prognostic role and HER2 expression of circulating tumor cells in peripheral blood of patients prior to radical cystectomy: a prospective study.
Rink M; Chun FK; Dahlem R; Soave A; Minner S; Hansen J; Stoupiec M; Coith C; Kluth LA; Ahyai SA; Friedrich MG; Shariat SF; Fisch M; Pantel K; Riethdorf S
Eur Urol; 2012 Apr; 61(4):810-7. PubMed ID: 22277196
[TBL] [Abstract][Full Text] [Related]
19. Circulating tumor cell status monitors the treatment responses in breast cancer patients: a meta-analysis.
Yan WT; Cui X; Chen Q; Li YF; Cui YH; Wang Y; Jiang J
Sci Rep; 2017 Mar; 7():43464. PubMed ID: 28337998
[TBL] [Abstract][Full Text] [Related]
20. CTCs in early breast cancer: A path worth taking.
Maltoni R; Gallerani G; Fici P; Rocca A; Fabbri F
Cancer Lett; 2016 Jul; 376(2):205-10. PubMed ID: 27060205
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
